The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is Alignment Healthcare (ALHC) one of those stocks right now? Let's take a closer look at the stock's year-to-date performance to find out. Alignment Healthcare is a member of our Medical group, which includes 999 different companies and currently sits at #5 in the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups. The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. Alignment Healthcare is currently sporting a Zacks Rank of #2 (Buy). The Zacks Consensus Estimate for ALHC's full-year earnings has moved 34.1% higher within the past quarter. This shows that analyst sentiment has improved and the company's earnings outlook is stronger. Based on the most recent data, ALHC has returned 44.4% so far this year. Meanwhile, stocks in the Medical group have lost about 4.8% on average. This means that Alignment Healthcare is outperforming the sector as a whole this year. BridgeBio Pharma (BBIO) is another Medical stock that has outperformed the sector so far this year. Since the beginning of the year, the stock has returned 22.8%. In BridgeBio Pharma's case, the consensus EPS estimate for the current year increased 8% over the past three months. The stock currently has a Zacks Rank #2 (Buy). Looking more specifically, Alignment Healthcare belongs to the Medical Services industry, a group that includes 58 individual stocks and currently sits at #52 in the Zacks Industry Rank. This group has lost an average of 1.9% so far this year, so ALHC is performing better in this area. BridgeBio Pharma, however, belongs to the Medical - Generic Drugs industry. Currently, this 11-stock industry is ranked #198. The industry has moved -15.1% so far this year. Going forward, investors interested in Medical stocks should continue to pay close attention to Alignment Healthcare and BridgeBio Pharma as they could maintain their solid performance. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Alignment Healthcare, Inc. (ALHC):Free Stock Analysis Report BridgeBio Pharma, Inc. (BBIO):Free Stock Analysis Report Story Continues This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research View Comments
Are Medical Stocks Lagging Alignment Healthcare (ALHC) This Year?
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...